Evidence map›Paper›PMID 39517371›Full record

ArticleHealthcare (Basel, Switzerland)2024

Anxiety and Depression Among Patients with Diabetes in Saudi Arabia and Egypt.

Madiha Rabie Mahmoud, Ahmed Aljadani, Ammar A Razzak Mahmood, Reem Falah Alshammari, Mona M Shahien, Somia Ibrahim, Ashraf Abdel Khalik, Fahaad S Alenazi, Fayez Alreshidi, Fatma Mohammad Nasr and 6 more

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Madiha Rabie MahmoudDepartment of Pharmacology, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.
Ahmed AljadaniDepartment of Internal Medicine, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.
Ammar A Razzak MahmoodDepartment of Pharmaceutical Chemistry, College of Pharmacy, University of Baghdad, Bab Al-Mouadam, Baghdad 10001, Iraq.ORCID 0000-0002-4915-417X
Reem Falah AlshammariDepartment of Family and Community Medicine, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.ORCID 0000-0002-5861-9960
Mona M ShahienDepartment of Pediatrics, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.
Somia IbrahimDepartment of Pediatrics, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.ORCID 0000-0002-4978-8324
Ashraf Abdel KhalikDepartment of Intensive Care Unit, TBRI, Ministry of Higher Education and Scientific Research, Giza 12411, Egypt.
Fahaad S AlenaziDepartment of Pharmacology, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.ORCID 0000-0003-4515-7055
Fayez AlreshidiDepartment of Family and Community Medicine, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.ORCID 0000-0002-2391-9090
Fatma Mohammad NasrDepartment of Intensive Care Unit, TBRI, Ministry of Higher Education and Scientific Research, Giza 12411, Egypt.ORCID 0000-0002-6801-6493
Hend Faleh AlreshidiDepartment of Family and Community Medicine, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.
Amal Daher AlshammariDepartment of Family and Community Medicine, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.ORCID 0000-0003-2501-6677
Marwa H AbdallahDepartment of Pharmaceutics, Faculty of Pharmacy, University of Ha'il, Ha'il 81442, Saudi Arabia.ORCID 0000-0001-6670-3903
Hemat El-Sayed El-HoranyDepartment of Biochemistry, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.ORCID 0000-0001-7790-7530
Kamaleldin B SaidDepartment of Pathology and Microbiology, College of Medicine, University of Ha'il, Ha'il 55476, Saudi Arabia.ORCID 0000-0002-3749-6754
Abdulrahman M SalehDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo 11562, Egypt.ORCID 0000-0002-5153-7399

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMental stress plagued type II diabetes (T2DM) patients. The psychological and emotional issues related to diabetes and its effects include depression, anxiety, poor diet, and hypoglycemia fear.

aimCompare the impact of diabetes on depression and anxiety in Egyptian and Saudi diabetics.

methodsThe diabetes, gastroenterology, and hepatology sections of University of Ha'il Clinic, KSA, and the Theodor Bilharz Research Institute, Egypt, conducted this retrospective study. Everyone gave informed consent before participating. Interviews with male and female outpatients and inpatients were conducted from June 2021 to December 2022. The self-administered validated Generalized Anxiety Disorder-7 (GAD-7) and the Patient Health Questionnaire-9 (PHQ-9) scale measured sociodemographic characteristics and symptoms of depression and anxiety.

resultsIn patients with diabetes, the prevalence of depression was higher in KSA [34.8%] than in Egypt [18%], while anxiety was higher in Egypt [40%] than in KSA [29.1%]. Most depressed patients were 31-55 years old (61.2%) from KSA and 97.8% (41-55 years old) from Egypt. Female anxiety was 70.7% in KSA and 51.0% in Egypt, with no significant difference. The duration of diabetes in depressed patients was 5-10 years ([46.9%, Saudis] vs. [57.8%, Egyptians]), while anxious patients (5-10 years [39.0%, Saudis] vs. >20 years [65.0%, Egyptians]) were mainly type-2. Most depressive patients had an HbA1c (59.2%) from 7-10% (Saudis) and 77.8% [>10% Egyptians] compared to anxiety patients (46.3%) and 48.0% [>10% Egyptians]. Depressed and anxious patients from both nations had higher glucose, triglycerides, and cholesterol levels. Saudis and Egyptians with obesity had higher rates of sadness (75.5% vs. 68.9%) and anxiety (82.9% vs. 69.0%). Treatment adherence and serum glucose monitoring were not significantly different from depression in diabetes individuals in both ethnicities.

conclusionsAnxiety was more common among Egyptian patients because of overcrowding, working whole days to fulfill life requirements, and the unavailability of health insurance to all citizens. Meanwhile, in KSA, obesity, unhealthy food, and less exercise reflect the high percentage of depression among patients with diabetes. The detection of depression and anxiety in the context of DM should be critical for the physical health and quality of life of Saudi and Egyptian diabetics. Further investigation is warranted to encompass anxiety and depression within the scope of future research.

Indexed as

anxietydepressionDiabetes Miletus type 2 (T2DM)EgyptHbA1cSaudi Arabia

Identifiers

PMID39517371
PMCPMC11544858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.